Skip to main content
Journal cover image

Poster: CT-314 Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials

Publication ,  Conference
Lin, C; Schwarzbach, A; Montesinos, P; Stiff, P; Cutler, C; Parikh, S; Brunstein, C; Lindemans, C; Hanna, R; Koh, LP; Maziarz, R; Keating, A ...
Published in: Clinical Lymphoma, Myeloma and Leukemia
September 28, 2022

Duke Scholars

Published In

Clinical Lymphoma, Myeloma and Leukemia

ISSN

2152-2669

Publication Date

September 28, 2022

Volume

22

Issue

Supp 2

Start / End Page

S442 / S442

Location

Houston, TX

Publisher

Elsevier

Conference Name

Society of Hematologic Oncology Annual Meeting

Related Subject Headings

  • Prospective Studies
  • Multicenter Studies as Topic
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • Follow-Up Studies
  • Disease-Free Survival
  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lin, C., Schwarzbach, A., Montesinos, P., Stiff, P., Cutler, C., Parikh, S., … Horwitz, M. (2022). Poster: CT-314 Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials. In Clinical Lymphoma, Myeloma and Leukemia (Vol. 22, pp. S442–S442). Houston, TX: Elsevier.
Lin, Chenyu, Aurelie Schwarzbach, Pau Montesinos, Patrick Stiff, Corey Cutler, Suhag Parikh, Claudio Brunstein, et al. “Poster: CT-314 Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.” In Clinical Lymphoma, Myeloma and Leukemia, 22:S442–S442. Elsevier, 2022.
Lin C, Schwarzbach A, Montesinos P, Stiff P, Cutler C, Parikh S, et al. Poster: CT-314 Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials. In: Clinical Lymphoma, Myeloma and Leukemia. Elsevier; 2022. p. S442–S442.
Lin, Chenyu, et al. “Poster: CT-314 Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.” Clinical Lymphoma, Myeloma and Leukemia, vol. 22, no. Supp 2, Elsevier, 2022, pp. S442–S442.
Lin C, Schwarzbach A, Montesinos P, Stiff P, Cutler C, Parikh S, Brunstein C, Lindemans C, Hanna R, Koh LP, Maziarz R, Keating A, Hwang W, Rezvani A, Valcarcel D, Fernandes J, Badell I, Jagasia M, Frankfurt O, Ram R, McGuirk J, Kurtzberg J, Sanz G, Simantov R, Horwitz M. Poster: CT-314 Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials. Clinical Lymphoma, Myeloma and Leukemia. Elsevier; 2022. p. S442–S442.
Journal cover image

Published In

Clinical Lymphoma, Myeloma and Leukemia

ISSN

2152-2669

Publication Date

September 28, 2022

Volume

22

Issue

Supp 2

Start / End Page

S442 / S442

Location

Houston, TX

Publisher

Elsevier

Conference Name

Society of Hematologic Oncology Annual Meeting

Related Subject Headings

  • Prospective Studies
  • Multicenter Studies as Topic
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • Follow-Up Studies
  • Disease-Free Survival
  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences